ProQuest Accepts Telehealth and Medicine Today to Global Databases!
Telehealth and Medicine Today (THMT) Accepted to ProQuest
We are pleased to share the open access Telehealth and Medicine Today (THMT) peer reviewed journal has been accepted to ProQuest, a Clarivate company.
ProQuest is a global distributor of aggregated, web-based research resources to the global library market expanding the reach and discovery of journal content. They help empower researchers, engage students, improve university workflows, and amplify women’s voices!
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, is a leading global data and analytics provider to academic, research and national institutions.
ProQuest product managers and editors are including Telehealth and Medicine Today (THMT) in the following databases:
We thank ProQuest for recognizing the multidisciplinary relevance Telehealth and Medicine Today brings to the global medical and healthcare ecosystem — at a time where practical telehealth applications and frontline innovations matter most!
Deadline for next Telehealth and Medicine Today issue: June 1, 2022.
Telehealth and Medicine Today (THMToday) is a gold open access international peer reviewed journal examining the value of telehealth and clinical automation, its use and scalable developments, business process guidance, market research and the economic impact of digital health innovations in an evolving health technology sector. Articles feature original research, pilot studies, case use, best practices and perspectives from multidisciplinary stakeholders. Authors are encouraged to submit outcomes data for cost efficiencies realized in health system(s), patient populations or clinical practices in a value based system. THMT’s audience includes leadership at hospitals and medical research centers, universities, payor organizations, IT/IS, healthcare providers, consultants, companies (early and more established), entrepreneurs, developers & start-ups, life sciences and device companies, pharmacy, NGO, government, and policy leadership around the globe.